key: cord-0919971-dl78j4f5
authors: Pormohammad, Ali; Ghorbani, Saied; Baradaran, Behzad; Khatami, Alireza; Turner, Raymond; Mansournia, Mohammad Ali; Kyriacou, Demetrios N.; Idrovo, Juan-Pablo; Bahr, Nathan C.
title: Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: A systematic review and meta-analysis
date: 2020-07-15
journal: Microb Pathog
DOI: 10.1016/j.micpath.2020.104390
sha: bcedc587bdea34b17871840b35e6e6ae16ffec43
doc_id: 919971
cord_uid: dl78j4f5

INTRODUCTION: In the current time where we face a COVID-19 pandemic, there is no vaccine or effective treatment at this time. Therefore, the prevention of COVID-19 and the rapid diagnosis of infected patients is crucial. METHOD: We searched all relevant literature published up to February 28, 2020. We used Random-effect models to analyze the appropriateness of the pooled results. RESULT: Eighty studies were included in the meta-analysis, including 61,742 patients with confirmed COVID-19 infection. 62.5% (95% CI 54.5–79, p < 0.001) of patients had a history of recent travel endemic area or contact with them. The most common symptoms among COVID-19 infected patients were fever 87% (95% CI 73–93, p < 0.001), and cough 68% (95% CI 55.5–74, p < 0.001)), respectively. The laboratory analysis showed that thrombocytosis was present in 61% (95% CI 41–78, p < 0.001) CRP was elevated in 79% (95% CI 65–91, p < 0.001), and lymphopenia in 57.5% (95% CI 42–79, p < 0.001). The most common radiographic signs were bilateral involvement in 81% (95% CI 62.5–87, p < 0.001), consolidation in 73.5% (95% CI 50.5–91, p < 0.001), and ground-glass opacity 73.5% (95% CI 40–90, p < 0.001) of patients. Case fatality rate (CFR) in <15 years old was 0.6%, in >50 years old was 39.5%, and in all range group was 6%. CONCLUSIONS: Fever and cough are the most common symptoms of COVID-19 infection in the literature published to date. Thombocytosis, lymphopenia, and increased CRP were common lab findings although most patients included in the overall analysis did not have laboratory values reported. Among Chinese patients with COVID-19, rates of hospitalization, critical condition, and hospitalization were high in this study, but these findings may be biased by reporting only confirmed cases.

In December 2019, the new COVID-19 coronavirus was recognized as a cause of respiratory illness. The first reports of pneumonia were from people who worked or lived in the Huanan seafood wholesale market in Wuhan, China raising concerns about a zoonotic viral infection [1, 2] . Phylogenetic analysis showed that the COVID-19 belong to the beta-coronavirus [1] .

Epidemiological studies have shown that the virus is spread relatively easily and can be transmitted by aerosol, droplets, and through infected surfaces [3] . The COVID-19 has now spread to more than 50 countries from December 2019 to February 2020 [4] . Most symptoms are non-specific in patients with respiratory disease. According to the latest WHO report, out of 83652 confirmed cases of COVID-19 worldwide, 2791 deaths occurred in China and 67 deaths is recorded in other countries [4] .

Thus far, 6 coronaviruses that are able to infect humans have been identified, coronavirus infections are typically asymptomatic or associated with mild respiratory symtoms [1] . The first coronavirus to cause severe disease in humans was the Severe Acute Respiratory Syndrome virus (SARS), which was appeared in the Guangdong province of southern China in 2002, there were 8098 reported case and 774 deaths [5] . In Saudi Arabia in 2012, the Middle East respiratory syndrome coronavirus (MERS-CoV), which was transmitted from the camels to humans, caused 2458 infections with 848 deaths [6] .

Clinical studies have shown that COVID-19 can rapidly cause pulmonary damage and severe respiratory symptoms [3] . There is no vaccine or targeted treatment currently available for COVID-19 infection. Treatment is largely supportive although multiple experimental antiviral medications are being evaluated [7, 8] . Thus, prevention and rapid diagnosis of infected patients is crucial. To date, the published clinical studies are quite small and give variable findings. With this in mind, here we evaluate the clinical features and laboratory findings using a large sample size of COVID-19 infected patients in order to assist in its understanding, prevention and treatment.

This study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (PRISMA) guidelines [9] . We searched all studies published up to February 28, 2020 from the following databases: Embase, Scopus, PubMed, Web of Science and the Cochrane library. Search medical subject headings (MeSH) terms used were: "COVID-19", "Coronavirus", "severe acute respiratory syndrome coronavirus", and all their synonyms like "Wuhan Coronavirus", "SARS-CoV-2", and "COVID-19". Moreover, we searched for unpublished and grey literature with Google scholar, Centre for Disease Controls (CDC) and WHO databases. We also examined references of included articles to find additional relevant studies. There was no language restriction and all included studies are written in English or Chinese languages, the latter were translated by https://translate.google.com/. Additional search strategy details are provided in Table S1 (supplementary material) [10] .

Duplicate studies were removed using EndNote X7 (Thomson Reuters, New York, NY, USA).

Records were initially screened by title and abstract by independently two authors (AP, SG).

The full-text of potentially eligible records was retrieved and examined. Any discrepancies were resolved by consensus.

Studies had to fulfil the following pre-determined criteria to be eligible for inclusion in our meta- 

Studies were excluded if they did not report number of confirmed cases, were letters to the editor or individual case reports or reviews. News reports were also excluded.

All included publications were published in 2020 and all patients are from China. The following items were extracted from each article: first author, Center and study location in China, sample collection time period, patient follow-up time, reference standard for infection confirmation, number of confirmed cases, and all demographic, clinical, laboratory data, and risk factor data.

Two of our authors (AP and SG) independently extracted data and differences were resolved by consensus.

Quality assessments of studies were performed by two reviewers independently according to the Critical Appraisal Checklist recommended by the Joanna Briggs Institute [11] , and disagreements were resolved by consensus. The checklist is composed of nine questions that reviewers addressed for each study. The 'Yes' answer for each question received one point.

Thus, final scores for each study could range from zero to nine ( Table S2 in Supplementary Material).

Data cleaning and preparation was done in Microsoft Excel 2010 (Microsoft©, Redmond, WA, USA) and further analyses were carried out via Comprehensive Meta-Analysis Software Version 2.0 (Biostat, Englewood, NJ). Determination of heterogeneity among the studies was undertaken using the chi-squared test (Cochran's Q) to assess the appropriateness of pooling data. We used Random effect model (M-H heterogeneity) for pooled results [12] . P values reflect study heterogeneity with <0.05 being significant. We also used the Begg's and Egger's tests based on the symmetry assumption to detect publication bias.

The process of study selection is displayed in Fig 1. A total of 36115 reports were screened for the analysis of patients with COVID-19, 36014 were excluded after title and abstract screening and the full text of 342 reports were reviewed in full text. We excluded studies that did not report sufficient data and finally 80 studies met the inclusion criteria (Figure 1) . Characteristics of the selected articles are summarized in Table 1 . Of the 80 studies that were included in the analysis, 79 studies were in English and the one of them was in the language of Chinese [13] . All studies were retrospective, published in 2020, and all patients were from China.

Quality assessment of included studies were performed based on the Critical Appraisal Checklist and the final scores for quality of included studies are represented in Table S2 (in supplementary  material) . In brief, studies by Chen [14] , Wang [15] , Huang [16] , Guan [17] , Zhang [18] , Cheng [19] , Li [20] , Wei Xu [21] , and Song [22] had the highest quality of the studies available in the purpose of this study.

Overall, 61, 742 confirmed patients with COVID-19 infection were included in the Metaanalysis, of which 55 % (95% CI 50-57.5, p < 0.001) were male. The most of the patients had fever 87 % (95% CI 73 -93, p < 0.001) and cough 68 % (95% CI 55.5-74, p < 0.001). A much smaller proportion of patients had sore throat 14% (95% CI 7.8-17, p 0.06), headache 14% (95% CI 8.3-18, p < 0.001), diarrhea 8% (95% CI 4.6-11.4, p < 0.001), rhinorrhea 7% (95% CI 3-12, p 0.43) or nausea and vomiting 6.5% (95% CI 2.7-13, p < 0.001). Most patients required hospitalization 81% (95% CI 68-94, p < 0.001), 25.6% (95% CI 6.7-48, p < 0.001) were deemed to be in critical condition and the mortality rate was 6% (95% CI 4-8.5, p < 0.001) between all infected patients. Table 3 shows that case fatality rate (CFR) in <15 years old age groups was 0.6 % (95% CI 0-0.9, p 1), >50 years old was 39.5 % (95% CI 28.5-52, p < 0.001) (Figure 2 ), all range group was 6 % (95% CI 4-8.5, p < 0.001) (Figure 3 ).

The majority of patients, 62.5% (95% CI 54.5-79, p < 0.001), had a history of recent travel endemic area or contact with them. A significant minority of patients (39.5%, 95% CI 20-56, p<0.001) had a history of chronic diseases and 26.5% (95% CI 9.6-49, p < 0.001) had exposure at the seafood market(s) ( Table 4) .

The laboratory analysis and features showed that the most infected patients had increased platelets 61% (95% CI 41-78, p < 0.001), and CRP 79% (95% CI 65-91, p < 0.001), while others showed decreased lymphocytes, 57.5% (95% CI 42-79, p < 0.001) ( Table 5) .

Analysis showed that the most abnormality which finding with Chest X-ray and CT are bilateral involvement of chest radiography 81% (95% CI 62.5-87, p < 0.001), consolidation 73.5% (95% CI 50.5-91, p < 0.001), and ground-glass opacity 73.5% (95% CI 40-90, p < 0.001) ( Table 6 ). virus has 84% homology to other beta-coronaviruses, 96% sequence similarity at the whole genome level to a bat coronavirus and 79.5 % similarity to the SARS virus [8, 25] . These results suggest that bats are important coronavirus reservoirs.

A study by Adam Bernheim, et al. showed that among 121 COVID-19 patients, fever, cough and sputum production were the most common clinical symptoms [3] . Our study found utilizing data from 52,251 patients with COVID-19 infection, that in additional to these, fatigue and myalgia (muscle soreness) were also common.

The large data set here finds that 81% of patients required hospitalization, 25.6% were found to be in critical condition and the mortality rate was 6% between all infected patients. The mortality rate is lower than some studies (for example, 11% in Nanshan, et al [14] ), but still higher than many viral infections. It should be recognized that these numbers are bias due to the data set including publications related to screening practices (e.g. only those with symptoms being screened) increased the % value. The true mortality rate from COVID-19 is almost certainly much lower than that found in this study. As more data emerges from screening asymptomatic or mildly symptomatic individuals in China and around the world, the true mortality rate will be better understood. Additionally, at the time of submission of this manuscript only ~50% of reported infected patients had recovered (gisanddata.maps.arcgis.com). Lymphopenia, age, multilobular infiltration, smoking history, hypertension, and bacterial co-infection have been reported as mortality risk factors. Underlying cardiovascular disease (40%) and bilateral pneumonia (81%) were common among those who have died. Recent travel endemic area or contact with them, exposure to persons with respiratory symptoms, and seafood market exposures were common amongst those contracting COVID-19. Among 2,361 COVID-19 patients with laboratory data available, leukocytosis was found in 18.3% and leukopenia in 28% with lymphocytopenia in 57.5%. Among 2200 patients, thrombocytosis occurred in 61% and in a smaller sample (n=290) CRP was increased in 79%.

normally expressed on pulmonary alveolar epithelial cells [26] . ACE2 activates the RAS cascade, which can lead to hypertension. The pathology in this pathway can also stimulate fibrogenesis, inflammation, cell hypertrophy, and cell proliferation [27, 28] . ACE2 expression is increased in people with pulmonary ARDS and acute respiratory injury [29] . The data collected here shows that ARDS occurred in 17.5 % of reported patients with COVID-19 infection.

Several limitations of this study exist. Publication bias and study heterogeneity are unavoidable in this type of study, therefore it should be considered when interpreting the outcomes of the reports and our final data set. Further, this study likely overestimates disease severity due to lack of screening of asymptomatic or mildly symptomatic individuals and subsequent publication bias related to these factors. It is very likely that many infected persons have not been detected, thus falsely elevating the rates of hospitalization, critical condition, and mortality.

Fever and cough are the most common symptoms of COVID-19 infection in the literature published to date. Thombocytosis, lymphopenia, and increased CRP were common lab findings although most patients included in the overall analysis did not have laboratory values reported.

The most common radiographic sign was bilateral involvement in and consolidation. Among Chinese patients with COVID-19, rates of hospitalization, critical condition, and hospitalization were high in this study, but these findings may be biased by reporting of only confirmed cases.

Competing interests: The authors have declared that no competing interests exist. Case fatality rate (CFR), * Greater than 50% is considered high heterogeneity, less than 50% is considered low heterogeneity. A low p value I'm no agree with reviewer comment, we did subgroup analysis based on our available data and we don't have reviewer recommended raw data. However, based on reviewer comments we divided forest plot to two different figs (however it was not necessary).

We hope this meets the established reputation for quality of your esteemed journal.

We updated our systematic review and included all new publication (80 papers, before we were included 20 papers). Given to importance of data, we would be appreciate if you could help to expedite the publication process.

Thank you very much for your consideration,

Reviewer #1: The revision is still not clear 1. The first forest plot is a big mix You can t mix different outcome in same figure The very risk of meta-analysis is bouillabaisse Please provide at least 2 figures for case fatality rate Figure 1 with all studies mentioning CFR Figure 2 with studies allowing you to identify age subgroup (please read carefully the tutorial of the software comprehensive meta-analysis) < 60 years 60 years and above Response: The first forest plot was not different outcome and all was CFR in different age groups, however based on your comments we divided CFR in two Figures: 1. Different age subgroups (< 15 and > 50), 2. All age groups (based on result order in the main text).

Our available raw data is < 15 and > 50 age groups, we don't have any raw data for > 60 and <60 years old. Therefore, we did subgroup analysis based on our available data.

A novel coronavirus from patients with pneumonia in China

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet

Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection

Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19) 2020

Overview on SARS in Asia and the world

Middle East Respiratory Syndrome Coronavirus Seropositivity in Camel Handlers and Their Families

Virtual screening of an FDA approved drugs database on two COVID-19 coronavirus proteins

Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Comparison of confirmed COVID-19 with SARS and MERS cases-Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis

The development of a critical appraisal tool for use in systematic reviews: Addressing questions of prevalence

Statistical aspects of the analysis of data from retrospective studies

Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Zhonghua jie he he hu xi za zhi= Zhonghua jiehe he huxi zazhi= Chinese journal of tuberculosis and respiratory diseases

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical characteristics of 2019 novel coronavirus infection in China

Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan

Kidney impairment is associated with inhospital death of COVID-19 patients. medRxiv

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

Emerging coronavirus 2019-nCoV pneumonia

Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human

Clinical Characteristics of 5732 Patients with 2019-nCoV Infection. Available at SSRN 3539664

Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin

Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan

ACE2 and microbiota: emerging targets for cardiopulmonary disease therapy

Molecular mechanism of vitamin D in the cardiovascular system

Angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Cellular and molecular life sciences

Early epidemiological analysis of the 2019-nCoV outbreak based on a crowdsourced data

Epidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China. medRxiv

Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv

Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia

Imaging profile of the COVID-19 infection: radiologic findings and literature review

Characteristics of COVID-19 Infection In Beijing

Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China

CT imaging features of 2019 novel coronavirus (2019-nCoV)

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Clinical characteristics of 82 death cases with COVID-19. medRxiv

Epidemiological and Clinical Features of Imported and Local Patients with Coronavirus Disease

Clinical features of critically ill patients with COVID-19 infection in China

Clinical, Radiological Characteristics and Outcomes of Medical Staff with COVID-19 in Wuhan

Analysis of death risk factors among 200 COVID-19 patients in Wuhan, China: a hospital-based case-cohort study

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet

Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multicentre case series

Clinical features and outcomes of 221 patients with COVID-19 in Wuhan

Clinical Features of 11 COVID-19 Patients with History of Thoracotomy: A Descriptive Study in Wuhan

Association between Clinical, Laboratory and CT Characteristics and RT-PCR Results in the Follow-up of COVID-19 patients. medRxiv

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. The Lancet Infectious Diseases

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive Study

Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit

Clinical Characteristics and Outcome of Medical Staff Infected with COVID-19 in Wuhan, China: A Retrospective Case Series Analysis. medRxiv

Clinical Characteristics on 25 Discharged Patients with COVID-19 Virus Returning. medRxiv

Epidemiological and Clinical Characteristics of COVID-19 Infection Outside Wuhan, China: A Multicenter Study

The cross-sectional study of hospitalized coronavirus disease

Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features

Clinical progression of patients with COVID-19 in Shanghai

Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study. The Lancet Digital Health

HRCT imaging features in representative imported cases of 2019 novel coronavirus pneumonia

A cluster of cases of severe acute respiratory syndrome in Hong Kong

Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chinese medical journal

Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan

Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing

Clinical Characteristics of 545 Cases Confirmed COVID-19 in Wuhan Stadium Cabin Hospital. Available at SSRN 3552844

The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China

Prediction of criticality in patients with severe Covid-19 infection using three clinical features: a machine learning-based prognostic model with clinical data in Wuhan

Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study

Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study

Epidemiological feature and outcome of 292 hospitalized patients with COVID-19 under adequate medical resource condition. Available at SSRN 3550016

Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State

In-flight Transmission Cluster of COVID-19: A Retrospective Case Series

Characteristics of ocular findings of patients with coronavirus disease 2019 (covid-19

Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan

Clinical Characteristics of 55 Cases of Deaths with COVID-19 Pneumonia in Wuhan, China: Retrospective Case Series

Clinical characteristics and durations of hospitalized patients with COVID-19 in Beijing: a retrospective cohort study. medRxiv

Clinical Characteristics and CT Manifestations of 143 Hospitalized Patients with 2019 Novel Coronavirus Disease (COVID-19) Outside Wuhan: A Multi

Epidemiological and Clinical Characteristics of 944 Cases of 2019 Novel Coronavirus Infection of Non-COVID-19 Exporting City

Clinical Characteristics of 85 Patients Infected by SARS-CoV-2 in Guangxi

Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan

Progression Course in 17 Discharged Patients: Comparison of Clinical and Thin-Section CT Features During Recovery

Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center

Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study

Epidemiologic and clinical characteristics of surgical patients infected with COVID-19 in Wuhan. Available at SSRN 3550044

Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy

Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019

Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China. medRxiv

Epidemiological and clinical characteristics of COVID-19 in Shenzhen, the largest migrant city of China. medRxiv

Clinical outcomes of 402 patients with

Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study

Clinical Characteristics and Risk Factors for Fatal Outcome in Patients with 2019-Coronavirus Infected Disease (COVID-19) in Wuhan. Available at SSRN 3546069

Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China

A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period. The Journal of infectious diseases

COVID-19 outbreak and surgical practice: unexpected fatality in perioperative period

Data-driven discovery of clinical routes for severity detection in COVID-19 pediatric cases. medRxiv

Full-length title: Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel medicine and infectious disease

ARDS=acute respiratory distress syndrome * Greater than 50% is considered high heterogeneity

CRP= C Reaction Protein, ESR= Erythrocyte sedimentation rate. WBCs= White blood cells *Increased or Decreased refers to values above or below the normal range

We respectfully submit our manuscript entitled "Clinical Characteristics, Laboratory

Infection: A Systematic Review and Meta-analysis" for consideration for publication in the Microbial Pathogenesis journal.This manuscript is not in consideration for publication elsewhere. All authors have contributed significantly to this manuscript and agree with its submission to this journal. The authors have no conflicts of interest to declare.

** Greater than 50% is considered high heterogeneity, less than 50% is considered low heterogeneity. A low p value (<.05) is consistent with high heterogeneity. CT scan= CT scan.